Foghorn Therapeutics
FHTX
FHTX
61 hedge funds and large institutions have $379M invested in Foghorn Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less capital invested
Capital invested by funds: $553M → $379M (-$174M)
98% less call options, than puts
Call options by funds: $3K | Put options by funds: $196K
Holders
61
Holding in Top 10
3
Calls
$3K
Puts
$196K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$7.26M | |
| 3 | +$3.64M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$892K |
Top Sellers
| 1 | -$5.75M | |
| 2 | -$5.49M | |
| 3 | -$3.41M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.36M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.43M |